Coronary Stent Market Size, Share, Trends Analysis | Global | 2023 – 2029 | MedCore | Segmented by: Type (Bare-Metal Stents, Drug-Eluting Stents)

  • Year: 2023
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

The global coronary stents market size is estimated to increase over the forecast period to reach a value of more than $4.8 billion in 2029. 

The majority of the global coronary stents market share was controlled by Boston Scientific, Medtronic and Abbott. Overall, this global market research includes an analysis of coronary stents companies spawning across more than 70 countries in the world.

Coronary Stents Market Data Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Coronary Stents Procedure Volumes
  • Market Drivers & Limiters for Each Market Segment
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

Coronary Stents Procedure Volumes

PICCs procedure volumes

Through this study on the global coronary stents market, iData Research has performed an analysis on the procedure volumes in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.

Coronary Stents Market Insights

The largest market for coronary stents was the Asia Pacific region. Unit sales growth for the total coronary stent market is highly correlated with the annual PCI procedure volume and any significant changes will have a direct effect on sales volume. In addition, systemic healthcare reforms, increased access to healthcare and increasing disposable income in this region are all expected to positively affect the market.

Coronary Stent Market By SegmentOverall, the global market size for coronary stents market is expected to grow over the forecast period. The ASP of the coronary stent market is heavily weighted towards the dominant DES segment, which accounted for the majority of the units sold. Prices of DESs have decreased substantially since they were first introduced in 2003. Some of the factors that influence price erosion include unfavorable reimbursement conditions and strong competition. Prices are expected to grow over the forecast period, driven by the trend of consolidation in the market.

Coronary Stents Market Share Insights

In 2022, the global coronary stents market was controlled by three key competitors – Boston Scientific, Medtronic and Abbott.

Boston Scientific is the leading competitor in the global coronary stent market. Most of the company’s success can be attributed to its strong position in the DES market, where it held the leading share. The company currently offers the PREMIER™ and SYNERGY™ DES product lines, as well as the REBEL™ BMS product line. SYNERGY™ is the first and only FDA-approved DES with abluminal bioabsorbable polymer coating available in the U.S. market. REBEL™ is made of platinum chromium alloy, which is designed to reduce device usage, procedure times and radiation exposure.

Research Regional Coverage

Throughout this research series, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Contact Us For Additional Information

For full segmentation and any questions regarding research coverage, please contact us or send a request by pressing one of the buttons on the right.

FREE Sample Report

Coronary Stent Market 166
6.1 Executive Summary 166
6.1.1 Global Coronary Stent Market Overview 166
6.1.2 Competitive Analysis 168
6.1.3 Procedures Included 169
6.1.4 Markets Included 170
6.1.5 Regions Included 171
6.2 Introduction 173
6.3 Procedure Numbers 175
6.4 Market Overview 189
6.4.1 By Segment 190
6.4.2 By Region 192
6.5 Market Analysis and Forecast 194
6.5.1 Total Coronary Stent Market 194
6.5.2 Bare-Metal Stent Market 198
6.5.3 Drug-Eluting Stent Market 202
6.6 Drivers and Limiters 206
6.6.1 Market Drivers 206
6.6.2 Market Limiters 207
6.7 Competitive Market Share Analysis 209
The Coronary Stents Market Report Suite| Global | 2023-2029 | MedCore includes analysis on the following companies currently active in this market:
  • Boston Scientific
  • Medtronic
  • Abbott
  • Biosensors
  • Biotronik
  • Alvimedica
  • Balton Medical
  • Barty Medical
  • Cardionovum
  • CeloNova
  • Cordis
  • Elixir Medical
  • Terumo
  • WEGO
  • And more.
Chart 6‑1: Coronary Stent Market, Global, 2022 & 2029 167
Chart 6‑2: Angioplasty/PCI Procedures, Global, 2022 167
Chart 6‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 177
Chart 6‑4: Coronary Stent Market by Segment, Global, 2019 – 2022 191
Chart 6‑5: Coronary Stent Market by Region, Global, 2019 – 2029 193
Chart 6‑6: Leading Competitors, Coronary Stent Market, Global, 2022 212
Figure 6‑1: Coronary Stent Procedures Covered 169
Figure 6‑2: Coronary Stent Markets Covered 170
Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2) 171
Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2) 172
Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 176
Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 178
Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) 179
Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) 180
Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 181
Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) 182
Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) 183
Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 184
Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) 185
Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) 186
Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) 187
Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 188
Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M) 190
Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M) 192
Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029 194
Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029 195
Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$) 196
Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M) 197
Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029 198
Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029 199
Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$) 200
Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M) 201
Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029 202
Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 203
Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$) 204
Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M) 205
Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022 211

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2023
  • 10 Years
  • Global
  • MedCore
SKU: iDATA_GLIC23_MC_CS Categories: , , , , , ,
Request Sample Sheets Request Customization
Related Reports
+

REQUEST SAMPLE SHEETS

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary

0
    0
    Your Cart
    Your cart is emptyReturn to Report Library